Cleared Traditional

ADVANTAGESIM MD MR PELVIC ORGAN AT RISK SEGMENTATION

K132944 · Ge Hungary Kft · Radiology
Mar 2014
Decision
176d
Days
Class 2
Risk

About This 510(k) Submission

K132944 is an FDA 510(k) clearance for the ADVANTAGESIM MD MR PELVIC ORGAN AT RISK SEGMENTATION, a System, Simulation, Radiation Therapy (Class II — Special Controls, product code KPQ), submitted by Ge Hungary Kft (Waukesha, US). The FDA issued a Cleared decision on March 14, 2014, 176 days after receiving the submission on September 19, 2013. This device falls under the Radiology review panel. Regulated under 21 CFR 892.5840.

Submission Details

510(k) Number K132944 FDA.gov
FDA Decision Cleared SESE
Date Received September 19, 2013
Decision Date March 14, 2014
Days to Decision 176 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code KPQ — System, Simulation, Radiation Therapy
Device Class Class II — Special Controls
CFR Regulation 21 CFR 892.5840

Similar Devices — KPQ System, Simulation, Radiation Therapy

All 69
ADVANTAGESIM MD WITH CT ATLAS-BASED CONTOURING AND RE-PLANNING OPTIONS
K132045 · Ge Hungary Kft · Sep 2013
RAD II SIMULATOR, RAD II KV IMAGER, DUAL RAD II KV IMAGER
K101038 · Acceletronics Digital Imaging, LLC · Aug 2010
ONCENTRA SIMULATION 2.3
K090706 · Nucletron Corporation · Jun 2009
IKOENGELO, VERSION 2
K083591 · Ikoetech, LLC · Dec 2008
INTEGRATED BRACHYTHERAPY UNIT - DIGITAL
K072445 · Nucletron Corp. · Sep 2007
IKOENGELO
K061006 · Ikoetech, LLC · Jun 2006